Changchun Bcht Biotechnology Co.

This early-stage study tests an mRNA vaccine designed to prevent genital herpes caused by HSV-2. About 144 healthy adults aged 18-55 will receive different doses to check safety and immune response. The goal is to see if the vaccine is safe and prompts the body to fight the virus…

This study tests a nasal spray flu vaccine in 200 people aged 3 to 17. Researchers will measure antibody levels in the nose to see how well the vaccine works. The goal is to understand the immune response and how long protection lasts.

This study tests a new rabies vaccine in 3,000 healthy people aged 10 to 60. The goal is to see if the vaccine triggers strong antibodies to prevent rabies after a possible exposure. Participants receive different shot schedules, and researchers check blood for immune response an…

This early-stage trial tests whether a new freeze-dried rabies vaccine is safe for people. Eighty healthy volunteers aged 10 to 60 received the vaccine and were monitored for side effects for 30 days. The goal is to prevent rabies, not to treat it.